Analysis of Green Hygienics, Inc. (GRHY)
Green Hygienics, Inc. (GRHY) has been showing consistent stability in its stock price over the past few days. The price has remained at $0.00600 with no significant fluctuations.
Technical indicators such as the Relative Strength Index (RSI) are indicating a value of 4.33572, which suggests that the stock is oversold. The Moving Average Convergence Divergence (MACD) indicator is close to zero, indicating a lack of strong momentum in either direction.
In terms of moving averages, the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) are all around $0.00601, slightly above the current price.
Overall, based on the current data, Green Hygienics, Inc. appears to be in a stable but potentially oversold position. Further analysis and monitoring of key indicators may be needed to assess potential future price movements.
Income statement 💸
These are the revenue figures. Here are the conclusions:
1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite the increase in sales, the cost of goods sold has also been rising, indicating a potential need for cost management.
3. The gross profit margin has remained relatively stable over the years, indicating efficient cost control measures.
4. Operating income has shown a positive trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
5. Net income has also been increasing consistently, from $57.4 billion in 2020 to $97 billion in 2023, showing a healthy growth trajectory.
6. Earnings per share (EPS) have shown a slight fluctuation but have generally been on an upward trend, indicating improved profitability per share.
7. The company has been able to maintain a stable number of outstanding shares, which is important for shareholders' equity.
8. Overall, the financial performance of the company in terms of revenue and profitability has been positive and shows a promising outlook for the future.
Balance Sheet
These are balance sheets. Here are the conclusions based on the provided data:
1. The total assets have been increasing over the years, reaching the highest value in 2023 at $352,583,000,000.
2. Current assets fluctuate slightly from year to year, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have been increasing steadily, with the highest value in 2023 at $209,017,000,000.
4. Total liabilities have also been increasing, reaching the highest value in 2023 at $290,437,000,000.
5. Shareholders' equity has been fluctuating, with the highest value in 2019 at $90,488,000,000.
6. The company has been relying more on non-current assets to support its growth, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been financing its growth through a combination of debt and equity, as indicated by the increase in both liabilities and shareholders' equity over the years.
Earnings
The company's results for the most recent quarter, as of April 30, 2025, have not been provided at this time. The previous results from February 27, 2025, were handled by the Transfer Agent. The results from January 31, 2025, were released after hours. The results from October 31, 2024, were not provided at the time. The results from August 1, 2024, showed an earnings per share (EPS) estimate of 1.32.
Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.
In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and the most recent quarter reported is March 2024. The company shows good returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price summary shows a beta value, moving averages, and the range of the stock price over the past fifty-two weeks.
Valuation metrics reveal the company's price-to-earnings ratios, enterprise value, price-to-book ratio, price-to-sales ratio, and market capitalization.
Lastly, dividends and splits information includes details about dividend rates, payout ratios, dividend dates, and historical splits.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:
1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase and issuance, as well as long-term debt issuance and payments.
6. Investing activities include significant amounts related to the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational performance and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:
1. For the current quarter ending on June 30, 2024, the average EPS estimate is $1.23, with a low estimate of $1.18 and a high estimate of $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter a year ago.
2. For the next quarter ending on September 30, 2024, the average EPS estimate is $1.42, with a low estimate of $1.33 and a high estimate of $1.51. This also indicates growth from the EPS of $1.35 in the same quarter last year.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS estimate is $6.10, ranging from a low of $5.95 to a high of $6.41. This reflects an increase from the EPS of $5.67 for the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average EPS estimate is $6.69, with a low estimate of $5.92 and a high estimate of $7.31. This suggests further growth compared to the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates point towards a positive trend of increasing earnings per share for the company in both the short term and the long term.
Revenue estimate
The analysts' estimates for the future quarterly and annual sales of the company are as follows:
1. **Current Quarter (2024-06-30)**
- Average Estimate: $77,545,400,000
- Low Estimate: $75,869,000,000
- High Estimate: $79,035,500,000
- Sales Growth: 2%
- Year Ago Sales: $75,725,200,000
- Number of Analysts: 25
2. **Next Quarter (2024-09-30)**
- Average Estimate: $85,501,800,000
- Low Estimate: $81,634,900,000
- High Estimate: $91,144,800,000
- Sales Growth: 3%
- Year Ago Sales: $82,854,600,000
- Number of Analysts: 25
3. **Current Year (2024-09-30)**
- Average Estimate: $357,772,000,000
- Low Estimate: $350,189,000,000
- High Estimate: $364,505,000,000
- Sales Growth: 1%
- Year Ago Sales: $354,834,000,000
- Number of Analysts: 38
4. **Next Year (2025-09-30)**
- Average Estimate: $380,772,000,000
- Low Estimate: $353,721,000,000
- High Estimate: $403,636,000,000
- Sales Growth: 6%
- Year Ago Sales: $357,772,000,000
- Number of Analysts: 38
**Key Takeaways:**
- The company is expected to see a steady increase in sales over the next few quarters and years.
- Analysts are generally optimistic about the company's growth prospects, with higher sales estimates for the next year compared to the current year.
- The number of analysts providing estimates is consistent across the different time periods, indicating a stable interest in the company's performance.
Growth estimates
Based on the consensus estimates provided:
- The company is expected to grow at a rate of 7.6% in the current year and 9.7% in the next year.
- For the current quarter and the next quarter, the growth rate is estimated to be around 5.1%.
- Over the next 5 years, the company is projected to grow at an annual rate of approximately 9.7%.
- However, in the past 5 years, the company has experienced a higher growth rate of around 20.1% per year.
Overall, it seems that the company is expected to maintain a solid growth trajectory, with a slightly higher growth rate projected for the future compared to the current period.
Price target
The analysts' forecast for the future price of the security is as follows:
- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions on the future price of the security, with the low end at $164, the high end at $275, and the average forecast at $204.58. The current price of the security is $192.25, which is below the average and median forecasted prices. Investors should consider these forecasts along with other factors when making investment decisions.MACD of GRHY